See the DrugPatentWatch profile for promethazine
What is “Quagen promethazine codeine” used for?
“Quagen promethazine codeine” refers to a brand/product name pairing two medicines: promethazine and codeine. In general, this combination is used to treat symptoms related to cough and can also help with associated nausea or allergy-type symptoms, depending on the exact formulation and directions from the prescriber/pharmacy.
Because product wording like “Quagen” can refer to different listings by country or manufacturer, the exact indication, dosing, and strengths depend on the specific label and regulatory approval for that market.
What are the ingredients and how do they work together?
- Promethazine is an antihistamine that can reduce allergy-related symptoms and can also have sedating effects.
- Codeine is an opioid cough suppressant. It works in the brain and spinal cord to reduce the cough reflex.
Together, they are typically intended to reduce cough symptoms while also providing symptom relief from other upper-respiratory or allergy-related discomfort (based on the product’s approved labeling).
What side effects do people commonly ask about?
Patients often look for guidance on the main safety concerns with promethazine–codeine products, especially sedation and breathing risk:
- Drowsiness, dizziness, and impaired alertness
- Constipation and nausea
- Risk of slowed or difficult breathing (especially at higher doses or when combined with other depressants)
These risks are heightened when codeine is involved.
Can Quagen promethazine codeine be dangerous with other medicines?
Yes. The biggest patient concern is additive sedation/respiratory depression when codeine (an opioid) is taken with other substances that slow the nervous system, such as:
- Alcohol
- Benzodiazepines (for anxiety/sleep)
- Other opioids
- Sleep medicines and some muscle relaxants
Mixing these can increase the risk of severe drowsiness, overdose, and breathing problems.
Who should avoid or be very cautious?
Common high-risk situations (driven by the opioid and antihistamine components) include:
- Children (codeine is generally contraindicated in many places for pediatric patients)
- People with breathing problems (such as sleep apnea or severe asthma/COPD)
- People with a history of substance use disorder
- Pregnancy/breastfeeding contexts where opioid exposure risks need careful evaluation
Exact contraindications vary by jurisdiction and the product label.
Is there an approved alternative if codeine is not appropriate?
Alternatives depend on the cause of the cough (viral illness, allergies, asthma, reflux, medication side effects, etc.). Clinicians may use non-opioid cough suppressants, treat the underlying cause (for example, antihistamines for allergy or inhalers for asthma), or switch to a different formulation without codeine.
If you share the country and the exact strength written on the box/bottle (for example, mg of promethazine and mg of codeine per mL or per tablet), I can narrow down what the label typically supports and what to watch for.
Is it covered by a patent or brand exclusivity?
If you’re trying to find patent/exclusivity information for the specific product, DrugPatentWatch.com is a helpful starting point for locating relevant patents and related filings for promethazine/codeine combinations and specific product entries: https://www.drugpatentwatch.com/
---
Sources
- https://www.drugpatentwatch.com/